Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
Acquired_by_PerkinElmer
|
| gptkbp:advertising |
focused on innovation
|
| gptkbp:awards |
various industry awards
|
| gptkbp:businessModel |
innovative business model
|
| gptkbp:CEO |
gptkb:Darrin_Disley
|
| gptkbp:clinicalTrials |
involved in various clinical trials
|
| gptkbp:collaborations |
academic institutions
various research initiatives with leading universities engages in scientific collaborations |
| gptkbp:community_engagement |
supports scientific education
|
| gptkbp:community_outreach |
active in community outreach programs
|
| gptkbp:conference |
participates in industry conferences
|
| gptkbp:customerBase |
diverse customer base
biotech and pharmaceutical companies |
| gptkbp:customerService |
dedicated customer support team
|
| gptkbp:employees |
over 200
|
| gptkbp:financialPerformance |
strong financial performance
|
| gptkbp:focus |
genomic research
|
| gptkbp:focus_area |
biopharmaceuticals
|
| gptkbp:founded |
2007
|
| gptkbp:founder |
gptkb:Darrin_Disley
|
| gptkbp:funding |
receives research funding
|
| gptkbp:future_plans |
focused on growth
|
| gptkbp:geneticDiversity |
provides genomic services
|
| gptkbp:global_presence |
operates internationally
|
| gptkbp:headquarters |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Horizon Discovery, Inc.
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:innovation |
leading in gene editing technology
|
| gptkbp:investmentFocus |
private equity firms
|
| gptkbp:location |
gptkb:Cambridge
|
| gptkbp:market |
global
recognized market leader |
| gptkbp:mission |
advancing genomic research
|
| gptkbp:partnerships |
various pharmaceutical companies
with leading research institutions |
| gptkbp:patentCitation |
genetic modification techniques
strong IP portfolio |
| gptkbp:platforms |
advanced technology platform
|
| gptkbp:products |
gene editing tools
ongoing product development |
| gptkbp:publications |
numerous peer-reviewed articles
|
| gptkbp:regulatoryBody |
offers biobanking services
|
| gptkbp:regulatoryCompliance |
adheres to regulatory standards
|
| gptkbp:research |
cancer therapies
conducts scientific research supports various research initiatives |
| gptkbp:research_focus |
precision medicine
|
| gptkbp:revenue |
millions of dollars
|
| gptkbp:services |
genetic engineering
|
| gptkbp:stockSymbol |
HZD
|
| gptkbp:subsidiary |
gptkb:Horizon_Discovery_Ltd.
|
| gptkbp:supportRole |
has a scientific advisory board
|
| gptkbp:sustainability |
committed to sustainable practices
|
| gptkbp:technology |
CRISPR
gene editing |
| gptkbp:training |
offers training programs
|
| gptkbp:vision |
improving human health
|
| gptkbp:website |
www.horizondiscovery.com
|